Screener Summaries Updates Institutions Sign In More Updates › Leadership & Pay › PODD Leadership & Pay · Jun 25, 2026
Insulet Corporation appointed Jonathan J. Mazelsky as a Class II director, effective July 1, 2026 PODD Insulet Corp
Insulet Corporation appointed Jonathan J. Mazelsky as a Class II director, effective July 1, 2026. Mr. Mazelsky, formerly the CEO of IDEXX Laboratories, Inc., will receive an initial grant of restricted stock units worth $216,548. Insulet Corporation is a medical technology company that develops and manufactures continuous glucose monitoring systems and insulin delivery systems.
More from Insulet Corp Insulet reports Q3 revenue of $842 million, up 19.2%, and authorizes $1 billion share buyback Nov 4, 2026 Insulet Corporation entered into the Ninth Amendment to its Credit Agreement on September 21, 2026 Sep 21, 2026 Insulet Corporation announced the departure of two Board members on September 3, 2026 Sep 10, 2026 Insulet Corporation reported second quarter 2026 financial results, announcing revenue of $801.7 million, a 23.5%… Aug 5, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
